Invitro International

Invitro International EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Invitro International (IVRO) as of Nov 3, 2026 is 25.31. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 32.25 — a change of -21.51% (lower).

EV/EBIT

25.31

YoY

-21.51%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Invitro International is 2025 25.31 . EV/EBIT (Enterprise Value to EBIT) of Invitro International was 2024 32.25 . It decreases by -21.51% lower compared to the previous year.

The Invitro International EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2017
54.10 USD
Jan 1, 2019
36.36 USD
Jan 1, 2020
70.40 USD
Jan 1, 2021
-82.22 USD
Jan 1, 2022
-18.86 USD
Jan 1, 2023
-86.93 USD
Jan 1, 2024
32.25 USD
Jan 1, 2025
25.31 USD
The Invitro International EV/EBIT history
YEAREV/EBITYoY
25.31-21.51%
32.25-137.10%
-86.93+360.81%
-18.86-77.06%
-82.22-216.80%
70.40+93.61%
36.36-32.79%
54.10+185.40%
18.96—
0.00—
0.00—
0.00—
0.00-100.00%
0.010.00%
0.01—
0.00—
0.00—
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Invitro International Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Invitro International's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Invitro International's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Invitro International's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Invitro International grows earnings faster than its peers.

Invitro International Stock analysis

What does Invitro International do? Invitro International is a leading company in the development of cell and tissue cultures as well as test systems for the pharmaceutical, cosmetic, and biotechnology industry. The company was founded in 1982 by Dr. George K. J. Uehara, a renowned scientist and specialist in the field of cell culture technology. His aim was to create a reliable alternative to animal testing to meet the industry's need for safe and effective test systems. Invitro International offers a wide range of products, including cell cultures and tissue samples derived from human or animal tissue. These are of the highest quality and are manufactured under strict quality controls. The tissue cultures are obtained from living organs and are ideal for the development of new drugs and cosmetics, as well as for studying the effects of environmental toxins and chemicals. Another focus of Invitro International is the development of test systems tailored to the needs of customers. These can include in vitro tests on cell and tissue cultures, as well as molecular analysis and screening methods. The company is divided into various industries and sectors, including pharmaceutical research, toxicology, cosmetics industry, biotechnology, and environmental research. Each of these sectors is supervised by specialized scientists and experts who have in-depth knowledge and experience in their respective fields. Invitro International places great emphasis on environmentally friendly and ethical standards in the development of new test systems and products. The company is also involved in various initiatives to promote alternatives to animal testing and actively advocates for the protection and welfare of animals. One of Invitro International's most well-known products is the Eye Irritation Test System (EITS), which is widely used in the cosmetics industry. It is a reliable in vitro test that determines the eye irritation potentials of new products based on human tissue. Invitro International has become a leading company in the field of cell culture technology and is now known worldwide for its high-quality products and services. The company takes pride in offering its customers safe, effective, and environmentally friendly test systems and is committed to continuing to develop innovative solutions to meet the industry's requirements. Invitro International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Invitro International stock

EV/EBIT (Enterprise Value to EBIT) of Invitro International is 25.31 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Invitro International changed from 32.25 to 25.31, representing a -21.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Invitro International since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Invitro International with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Invitro International

All Key Metrics — Invitro International